Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF800 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
mRNA | RP11-515E23.1 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
mRNA | PLA2G7 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
mRNA | SCAF4 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
mRNA | SLC16A14 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
mRNA | FOXD2 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
mRNA | KRT18 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
mRNA | PDCD1 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
mRNA | BMT2 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
mRNA | CENPE | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |